For example, diabetes mellitus (DM) patients in Ethiopia exhibited a pooled utility value of 0.78, with significant heterogeneity driven by factors like diabetic complications (neuropathy, nephropathy, retinopathy), comorbidities (hypertension, cardiovascular diseases), older age, and insulin therapy. This evidence concerns the gene INS and cardiovascular disorder.